ICD-10-CM Billable Code

T36.AX5

Adverse effect of fluoroquinolone antibiotics

Clinical Classification Guidelines

Medical Intelligence & Overview

Fluoroquinolone antibiotics are a widely used class of medications prescribed for various bacterial infections. While effective in combating bacteria, they can sometimes cause adverse effects that require attention. The ICD-10 code T36.AX5 is used to document cases where patients experience negative reactions to these antibiotics. Recognizing these effects is important for appropriate management and care.

Causes & Symptoms

Clinical Causes: Use of fluoroquinolone antibiotics such as ciprofloxacin, levofloxacin, ofloxacin, or moxifloxacin Individual hypersensitivity or allergic reactions to the medication Accumulation of the drug in patients with impaired kidney or liver function Concurrent use with other medications that increase the risk of side effects Extended duration of therapy or higher-than-recommended doses

Key Symptoms: Gastrointestinal issues like nausea, vomiting, or diarrhea Neurological symptoms such as dizziness, headache, or confusion Tendon pain, swelling, or rupture, especially in the Achilles tendon Skin reactions including rash, itching, or photosensitivity Assessments indicating peripheral neuropathy or muscle weakness In some cases, signs of tendinitis or joint discomfort

Diagnostic & Treatment

Diagnosis Path: Diagnosis of adverse effects related to fluoroquinolone antibiotics involves a thorough review of recent medication intake, symptom presentation, and medical history. Physicians may perform physical examinations and order lab tests or imaging studies to rule out other causes and confirm drug-related reactions. Vigilance is essential for early detection, especially with symptoms like tendon pain or neurological changes.

Treatment Protocols: Management usually includes discontinuation of the offending antibiotic. Supportive care is tailored to the specific adverse effect, such as pain management for tendinitis or neurological symptoms. In severe cases, hospitalization may be necessary. Patients are advised to report any unusual symptoms promptly to healthcare providers for appropriate intervention. Preventative measures include adhering to prescribed doses and durations, as well as informing providers of any allergies or pre-existing conditions.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T36.AX5 a billable ICD-10 code?
Yes, T36.AX5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T36.AX5?
Clinical documentation must specify the nature of Adverse effect of fluoroquinolone antibiotics and any associated comorbidities for accurate reporting.

Cite this Clinical Reference